dipyridamole has been researched along with Thromboembolism in 162 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Thromboembolism: Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The preventive effect of 300 mg/day dipyridamole, plus warfarin, on the development of thromboembolism after cardiac valve replacement was evaluated." | 9.06 | Dipyridamole combined with anticoagulant in prevention of early postoperative thromboembolism after cardiac valve replacement. ( Fujita, T; Kawazoe, K; Manabe, H, 1990) |
| "In a prospective, randomized, parallel study, two regimens of platelet-suppressant therapy (PST)--dipyridamole-aspirin and pentoxifylline-aspirin--were compared with standard oral anticoagulation with warfarin in the prevention of prosthetic heart valve thromboembolism." | 9.05 | Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial. ( Boey, J; Chan, TK; Cheung, KL; Chow, J; Lee, PK; Mok, CK; Ng, RP; Tse, TF; Wang, R, 1985) |
| "To resolve questions of drug actions, efficacy, and interactions for platelet-modifying agents used clinically, we have compared the relative capacities and mechanisms of aspirin, dipyridamole, sulfinpyrazone, and dazoxiben to prevent arterial thromboembolism in a baboon model." | 7.67 | Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition. ( Bjornsson, TD; Hanson, SR; Harker, LA, 1985) |
| "The preventive effect of 300 mg/day dipyridamole, plus warfarin, on the development of thromboembolism after cardiac valve replacement was evaluated." | 5.06 | Dipyridamole combined with anticoagulant in prevention of early postoperative thromboembolism after cardiac valve replacement. ( Fujita, T; Kawazoe, K; Manabe, H, 1990) |
| "In a prospective, randomized, parallel study, two regimens of platelet-suppressant therapy (PST)--dipyridamole-aspirin and pentoxifylline-aspirin--were compared with standard oral anticoagulation with warfarin in the prevention of prosthetic heart valve thromboembolism." | 5.05 | Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial. ( Boey, J; Chan, TK; Cheung, KL; Chow, J; Lee, PK; Mok, CK; Ng, RP; Tse, TF; Wang, R, 1985) |
| "Aspirin has been shown to reduce the number of transient ischemic attacks (TIA), stroke and death in patients with multiple TIA." | 3.75 | Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells. ( Turpie, AG, 1982) |
| "In acute ischemic stroke and transient ischemic attack (TIA), aspirin is recommended to all patients (except immediately following thrombolysis)." | 3.74 | [Antithrombotic therapy in ischemic stroke and transient ischemic attack]. ( Husted, SE; Overgaard, K; Poulsen, TS, 2007) |
| "Addition of platelet inhibitors to heparin/phenprocoumon effectively prevents thromboembolism." | 3.70 | Effect of platelet inhibitors on thromboembolism after implantation of a Novacor N100--preliminary results. ( Deng, MC; Hammel, D; Nabavi, D; Scheld, HH; Schmid, C; Weyand, M, 1998) |
| "Thirty patients (18 women, 12 men) with permanent or paroxysmal atrial fibrillation were treated with a new antiplatelet drug, ticlopidine, in order to study platelet aggregation behaviour, to see whether the drug prevents thromboembolisms and to observe side-effects over a period of 6 months." | 3.67 | Platelet aggregation behaviour in patients treated with ticlopidine. ( Balbarini, A; Evangelisti, L; Gherarducci, G; Giordani, R; Mariani, M; Petronio, AS; Preti, R, 1987) |
| "To resolve questions of drug actions, efficacy, and interactions for platelet-modifying agents used clinically, we have compared the relative capacities and mechanisms of aspirin, dipyridamole, sulfinpyrazone, and dazoxiben to prevent arterial thromboembolism in a baboon model." | 3.67 | Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition. ( Bjornsson, TD; Hanson, SR; Harker, LA, 1985) |
| "In a prospective study, the efficacy of a dipyridamole-aspirin regimen in prevention of thromboembolism was evaluated in 50 patients having isolated aortic valve replacement with the Model 2320 Starr-Edwards prosthesis." | 3.66 | Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis. ( Bowen, TE; Brott, WH; Davia, J; Green, DC; Zajtchuk, R, 1981) |
| " In the 33rd week of pregnancy, previous warfarin sodium therapy was discontinued and dipyridamole therapy instituted." | 3.65 | Cesarean section in a patient with a mitral valve prosthesis. ( Ben-Adereth, N; Biale, Y; Gueron, M; Lewenthal, H, 1975) |
| "The safety of a very low level of anticoagulation combined with dipyridamole in a rheumatic population (mean age 31 +/- 13 years) with the St." | 2.67 | Frequency of prosthetic valve-related complications with very low level warfarin anticoagulation combined with dipyridamole after valve replacement using St. Jude Medical prostheses. ( Bedhesi, S; Dullabh, A; Essop, AR; Essop, MR; Sareli, P; Skoularigis, J; Skudicky, D; Strugo, V; Wisenbaugh, T, 1994) |
| "The risk of major bleeding is increased with antiplatelet therapy." | 2.49 | Antiplatelet and anticoagulation for patients with prosthetic heart valves. ( Little, SH; Massel, DR, 2013) |
| " With the antiplatelet agents, unpredictability in the pharmacokinetic parameters of different products has confounded interpretation of published reports." | 2.39 | Pharmacokinetic optimisation of the treatment of embolic disorders. ( Bottorff, M; Lutomski, DM; Sangha, K, 1995) |
| "Clinically symptomatic deep venous thrombosis was detected in association with four (0." | 1.34 | Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment. ( Boutary, M; Dorr, LD; Gendelman, V; Long, WT; Maheshwari, AV; Wan, Z, 2007) |
| "The intramural coronary arteriosclerosis showed thickening of the wall due to medial hyperplasia by fibrosis, and arterial stenosis." | 1.33 | Chronic myocardial infarction due to arteriosclerosis of coronary arteries followed by acute thromboembolism of caudal abdominal aorta in a cat. ( Hikasa, Y; Minami, S; Morita, T; Okamoto, Y; Shimada, A; Tsujino, K, 2005) |
| "Phenindione has been the anticoagulant of choice." | 1.31 | Standard versus low-level anticoagulation combined to low-dose dipyridamole after mitral valve replacement. ( Allam, H; Awad, A; Hassaballah, F; Hassouna, A, 2000) |
| "Among 801 patients not receiving treatment for thromboembolism, the annual rate was 0." | 1.30 | [Atrial fibrillation and thromboembolism: a multicenter cooperative study. Research Group for Antiarrhythmic Drug Therapy]. ( , 1998) |
| "Aspirin was administered in daily doses of 20 mg/kg, dipyridamole in daily doses of 2." | 1.27 | Effective antiplatelet drug concentrations in experimental arterial thromboembolism. ( Bjornsson, TD; Hanson, SR; Harker, LA, 1987) |
| "Warfarin-treated patients were at increased risk of hemorrhage (5 of 20 [25%], or 22 per 100 patient-years, vs 0 of 10 [0%], or 0 per 100 patient-years, p less than 0." | 1.27 | Anticoagulation therapy in children with mechanical prosthetic cardiac valves. ( Bradley, LM; Getson, PR; Midgley, FM; Scott, LP; Watson, DC, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 137 (84.57) | 18.7374 |
| 1990's | 13 (8.02) | 18.2507 |
| 2000's | 11 (6.79) | 29.6817 |
| 2010's | 1 (0.62) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Massel, DR | 2 |
| Little, SH | 3 |
| Tibbles, HE | 1 |
| Samuel, P | 1 |
| Erbeck, D | 1 |
| Mahajan, S | 1 |
| Uckun, FM | 1 |
| Nicholls, C | 1 |
| Sani, M | 1 |
| Tsujino, K | 1 |
| Hikasa, Y | 1 |
| Minami, S | 1 |
| Okamoto, Y | 1 |
| Morita, T | 1 |
| Shimada, A | 1 |
| Jamieson, DG | 1 |
| Overgaard, K | 1 |
| Poulsen, TS | 1 |
| Husted, SE | 1 |
| Dorr, LD | 1 |
| Gendelman, V | 1 |
| Maheshwari, AV | 1 |
| Boutary, M | 1 |
| Wan, Z | 1 |
| Long, WT | 1 |
| Johnson, SG | 1 |
| Rogers, K | 1 |
| Delate, T | 1 |
| Witt, DM | 1 |
| Jayaswal, U | 1 |
| Bolte, HD | 1 |
| Westermann, K | 1 |
| Trentz, O | 1 |
| Pretschner, P | 1 |
| Mellmann, J | 1 |
| Tullio, D | 1 |
| Boccaccio, P | 1 |
| Ghio, R | 1 |
| Ratti, M | 1 |
| Casciaro, S | 1 |
| Rattenni, S | 1 |
| Sergnese, G | 1 |
| Weinstein, GS | 1 |
| Mavroudis, C | 1 |
| Ebert, PA | 2 |
| Murray, PD | 1 |
| Garnic, JD | 1 |
| Bettmann, MA | 1 |
| Sherry, S | 3 |
| Chesebro, JH | 4 |
| Fuster, V | 6 |
| Elveback, LR | 1 |
| McGoon, DC | 1 |
| Pluth, JR | 2 |
| Puga, FJ | 2 |
| Wallace, RB | 1 |
| Danielson, GK | 2 |
| Orszulak, TA | 2 |
| Piehler, JM | 1 |
| Schaff, HV | 1 |
| Fitzpatrick, JW | 1 |
| Giudice, JC | 1 |
| Papa, L | 1 |
| Freed, N | 1 |
| Ordinas, A | 1 |
| Kigasawa, K | 1 |
| Saitoh, K | 1 |
| Iwadate, K | 1 |
| Ohkubo, K | 1 |
| Irino, O | 1 |
| Bouchier-Hayes, D | 1 |
| Asano, H | 1 |
| Shimada, E | 1 |
| Kurasawa, T | 1 |
| Matumoto, K | 1 |
| Yamane, Y | 1 |
| Hladovec, J | 1 |
| Verstraete, M | 4 |
| Starkman, C | 1 |
| Estampes, B | 1 |
| Vernant, P | 1 |
| Acar, J | 1 |
| Shattil, SJ | 1 |
| Brass, LF | 1 |
| Poliwoda, H | 1 |
| Sano, T | 1 |
| Motomiya, T | 1 |
| Yamazaki, H | 1 |
| O'Grady, J | 1 |
| Bunting, S | 1 |
| Moncada, S | 1 |
| Sternon, J | 1 |
| Turpie, AG | 1 |
| Feri, P | 1 |
| Guaschino, S | 1 |
| Pesando, P | 1 |
| Preseglio, I | 1 |
| Brott, WH | 1 |
| Zajtchuk, R | 1 |
| Bowen, TE | 1 |
| Davia, J | 1 |
| Green, DC | 1 |
| Donner, L | 1 |
| Bran, M | 1 |
| Capel, P | 1 |
| Messin, R | 1 |
| Croveri, G | 1 |
| Pouleur, H | 1 |
| Buyse, M | 1 |
| Lutomski, DM | 1 |
| Bottorff, M | 1 |
| Sangha, K | 1 |
| Heras, M | 1 |
| Penny, WJ | 1 |
| Grill, DE | 1 |
| Bailey, KR | 1 |
| Skudicky, D | 1 |
| Essop, MR | 1 |
| Wisenbaugh, T | 1 |
| Skoularigis, J | 1 |
| Essop, AR | 1 |
| Dullabh, A | 1 |
| Bedhesi, S | 1 |
| Strugo, V | 1 |
| Sareli, P | 1 |
| LeBlanc, JG | 1 |
| Sett, SS | 1 |
| Vince, DJ | 1 |
| Altman, R | 2 |
| Rouvier, J | 2 |
| Gurfinkel, E | 2 |
| Humphreys, DM | 1 |
| Bradley, SM | 1 |
| Sade, RM | 1 |
| Crawford, FA | 1 |
| Stroud, MR | 1 |
| Schmid, C | 1 |
| Weyand, M | 1 |
| Hammel, D | 1 |
| Deng, MC | 1 |
| Nabavi, D | 1 |
| Scheld, HH | 1 |
| Yamak, B | 1 |
| Iscan, Z | 1 |
| Mavitas, B | 1 |
| Ulus, AT | 1 |
| Katircioglu, SF | 1 |
| Tasdemir, O | 1 |
| Bayazit, K | 1 |
| Hassouna, A | 1 |
| Allam, H | 1 |
| Awad, A | 1 |
| Hassaballah, F | 1 |
| Galindo, G | 1 |
| Peiró, R | 1 |
| Plana, A | 1 |
| Navarro, MA | 1 |
| Berdié, J | 1 |
| Morató, J | 1 |
| Massel, D | 1 |
| Jobin, F | 1 |
| Serradimigni, A | 1 |
| Loo, J | 1 |
| Björk, VO | 1 |
| Henze, A | 1 |
| Ahmad, R | 1 |
| Rajah, SM | 2 |
| Mearns, AJ | 1 |
| Deverall, PB | 2 |
| Harker, LA | 11 |
| Hanson, SR | 3 |
| Rubegni, M | 1 |
| Provvedi, D | 1 |
| Bellini, PG | 1 |
| Bandinelli, C | 1 |
| De Mauro, G | 1 |
| Deykin, D | 1 |
| Gurewich, V | 1 |
| Harker, L | 1 |
| Hirsch, J | 1 |
| Didisheim, P | 2 |
| Kher, A | 2 |
| Toulemonde, F | 1 |
| Frick, U | 1 |
| Frick, G | 1 |
| Hirsh, J | 11 |
| Uhl, JF | 1 |
| Huguier, M | 1 |
| Dettori, AG | 1 |
| Pini, M | 1 |
| Quintavalla, R | 1 |
| Ostendorf, P | 1 |
| Gantmacher, ML | 1 |
| Hansen, MS | 1 |
| Christensen, BE | 1 |
| Jønsson, V | 1 |
| Rao, S | 1 |
| Watson, DA | 2 |
| Zekert, F | 2 |
| Sutton, MG | 1 |
| Miller, GA | 1 |
| Oldershaw, PJ | 1 |
| Paneth, M | 1 |
| Wyss, M | 1 |
| Diez, C | 1 |
| Balavoine, JF | 1 |
| Martin, D | 1 |
| Bouvier, CA | 2 |
| Bucher, HJ | 1 |
| Gent, M | 5 |
| Genton, E | 7 |
| Klimt, CR | 1 |
| Doub, PH | 1 |
| Doub, NH | 1 |
| Gallus, AS | 1 |
| Aledort, LM | 1 |
| Morris, GK | 1 |
| Mitchell, JR | 1 |
| Coeugniet, E | 2 |
| de Gaetano, G | 1 |
| Donati, MB | 1 |
| Garattini, S | 1 |
| Steele, P | 2 |
| Weily, H | 1 |
| Davies, H | 1 |
| Ppppas, G | 1 |
| Dale, J | 2 |
| Myhre, E | 1 |
| Rootwelt, K | 1 |
| Biale, Y | 1 |
| Lewenthal, H | 1 |
| Gueron, M | 1 |
| Ben-Adereth, N | 1 |
| Hellinger, J | 1 |
| Seidel, M | 1 |
| Kakkar, VV | 1 |
| Ellis, J | 1 |
| Buchanan, M | 1 |
| Dechavanne, M | 1 |
| Ville, D | 1 |
| Viala, JJ | 1 |
| Faivre, J | 1 |
| Pousset, MB | 1 |
| Dejour, H | 1 |
| Dumke, HO | 1 |
| van Cauwenberge, H | 1 |
| Sumida, S | 1 |
| D'Ortencio, O | 1 |
| Manzanel, R | 1 |
| de La Fuente, L | 1 |
| Favaloro, RG | 1 |
| Kawazoe, K | 1 |
| Fujita, T | 1 |
| Manabe, H | 1 |
| Franzoni, P | 1 |
| Cuccia, C | 1 |
| Zappa, C | 1 |
| Volpini, M | 1 |
| Gei, P | 1 |
| Visioli, O | 1 |
| Strano, A | 1 |
| Davì, G | 1 |
| Cannizzaro, S | 1 |
| Giubilato, A | 1 |
| Lavie, CJ | 1 |
| Squires, RW | 1 |
| Gau, GT | 1 |
| Steele, PM | 1 |
| Saitoh, H | 1 |
| Matsumoto, H | 1 |
| Yagyu, K | 1 |
| Miyawaki, F | 1 |
| Ide, H | 1 |
| Furuse, A | 1 |
| Bjornsson, TD | 2 |
| da Rocha Neto, JM | 1 |
| da Rocha Filho, JM | 1 |
| da Rocha, AM | 1 |
| Resnekov, L | 1 |
| Chediak, J | 1 |
| Lewis, D | 1 |
| Petronio, AS | 1 |
| Evangelisti, L | 1 |
| Preti, R | 1 |
| Gherarducci, G | 1 |
| Balbarini, A | 1 |
| Giordani, R | 1 |
| Mariani, M | 1 |
| Nuñez, L | 1 |
| Pinto, AG | 1 |
| Larrea, JL | 1 |
| Gil Aguado, M | 1 |
| Connor, FO | 1 |
| Nitter-Hauge, S | 1 |
| Verrier, ED | 1 |
| Tranbaugh, RF | 1 |
| Soifer, SJ | 1 |
| Yee, ES | 1 |
| Turley, K | 1 |
| Nordestgaard, AG | 1 |
| Buckels, JA | 1 |
| Wilson, SE | 1 |
| Delahaye, JP | 1 |
| Milon, H | 1 |
| Ffrench, P | 1 |
| Philippe-Bert, J | 1 |
| Malquarti, V | 1 |
| Saradarian, W | 1 |
| Mok, CK | 1 |
| Boey, J | 1 |
| Wang, R | 1 |
| Chan, TK | 1 |
| Cheung, KL | 1 |
| Lee, PK | 1 |
| Chow, J | 1 |
| Ng, RP | 1 |
| Tse, TF | 1 |
| Ciavarella, N | 1 |
| Antoncecchi, S | 1 |
| D'Elia, N | 1 |
| Ribeiro, PA | 1 |
| Al Zaibag, M | 1 |
| Idris, M | 1 |
| Al Kasab, S | 1 |
| Davies, G | 1 |
| Mashat, E | 1 |
| Wareham, E | 1 |
| Al Fagih, M | 1 |
| Bradley, LM | 1 |
| Midgley, FM | 1 |
| Watson, DC | 1 |
| Getson, PR | 1 |
| Scott, LP | 1 |
| Loeliger, EA | 1 |
| de la Cruz Cortés, JP | 1 |
| Aguilar Muñoz, A | 1 |
| Martos Crespo, F | 1 |
| Rubio Santiago, M | 1 |
| Sánchez de la Cuesta, F | 1 |
| Loew, D | 1 |
| Vormittag, E | 1 |
| Kohn, P | 1 |
| Grabner, H | 1 |
| Vormittag, D | 1 |
| Ogston, D | 1 |
| Douglas, AS | 1 |
| Schnetzer, GW | 1 |
| Manohitharajah, SM | 1 |
| Rahman, AN | 1 |
| Donnelly, RJ | 1 |
| Dragojevic, D | 1 |
| Hetzer, R | 1 |
| Corterier, H | 1 |
| Wessler, S | 1 |
| Sherman, LA | 1 |
| Mandel, SR | 1 |
| Johnson, G | 1 |
| Kazmier, FJ | 1 |
| Stiehler, R | 1 |
| Slichter, SJ | 3 |
| Ibarra-Pérez, C | 1 |
| Bounameaux, Y | 1 |
| Weiss, HJ | 2 |
| Kummer, H | 1 |
| Hunziker, HR | 1 |
| Althaus, U | 1 |
| Sullivan, JM | 4 |
| Harken, DE | 5 |
| Gorlin, R | 4 |
| Matloff, JM | 2 |
| Collins, JJ | 1 |
| Stuart, M | 1 |
| Stockman, J | 1 |
| Murphy, S | 1 |
| Schut, L | 1 |
| Ames, M | 1 |
| Urmson, J | 1 |
| Oski, F | 1 |
| Arrants, JE | 1 |
| Hairston, P | 1 |
| Adura, M | 1 |
| Guerra, JC | 1 |
| Salzman, EW | 1 |
| Harris, WH | 1 |
| DeSanctis, RW | 1 |
| Garcia, AB | 1 |
| Silva Cazares, JH | 1 |
| Ladron de Guevara, HR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| "Transcranial Doppler Assessment of Cerebral Embolization During Early Anti-thrombotic Therapy After Bioprosthetic Aortic Valve Replacement: Comparison of High-dose Aspirin Versus Warfarin Plus Low-dose Aspirin"[NCT00465218] | 56 participants (Actual) | Observational | 2007-03-31 | Completed | |||
| In-vivo Thrombus Imaging With 18F-GP1, a Novel Platelet PET Radiotracer[NCT03943966] | 73 participants (Actual) | Interventional | 2019-11-11 | Completed | |||
| Observatory of Anticoagulation After Bioprosthetic Aortic Valve Replacement[NCT01293188] | 434 participants (Actual) | Observational | 2011-01-31 | Completed | |||
| Dabigatran Versus Warfarin After Mitral and Aortic Bioprosthesis Replacement for the Management of Atrial Fibrillation Postoperatively: Pilot Study[NCT01868243] | Phase 2/Phase 3 | 27 participants (Actual) | Interventional | 2013-08-31 | Terminated (stopped due to because a significant decrease of viable candidates for the study.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The primary endpoint was the detection of intracardiac thrombus in TEE at the end of follow-up (90 days). (NCT01868243)
Timeframe: 90 days
| Intervention | participants (Number) |
|---|---|
| Dabigatran | 0 |
| Warfarin | 1 |
Spontaneous Echo Contrast showed in Transesophageal echocardiography (NCT01868243)
Timeframe: 90 days
| Intervention | participants (Number) |
|---|---|
| Dabigatran | 2 |
| Warfarin | 1 |
48 reviews available for dipyridamole and Thromboembolism
| Article | Year |
|---|---|
Antiplatelet and anticoagulation for patients with prosthetic heart valves.
Topics: Administration, Oral; Anticoagulants; Aspirin; Dipyridamole; Drug Therapy, Combination; Heart Valve | 2013 |
Antiplatelet and anticoagulation for patients with prosthetic heart valves.
Topics: Anticoagulants; Aspirin; Dipyridamole; Heart Valve Prosthesis; Humans; Platelet Aggregation Inhibito | 2003 |
[Role of antiaggregant platelet drugs in thromboembolism].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anti-Bacterial Agents; Aspirin; Cerebrova | 1981 |
[Disseminated intravascular coagulation. II. Therapeutic problems].
Topics: Antifibrinolytic Agents; Antithrombin III Deficiency; Anuria; Aprotinin; Aspirin; Blood Transfusion; | 1982 |
Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypas | 1982 |
Eicosanoids and venous thromboembolism.
Topics: Animals; Arachidonic Acids; Aspirin; Dipyridamole; Dogs; Epoprostenol; Hemostasis; Humans; Platelet | 1983 |
[Current clinical results of antiplatelet medication].
Topics: Animals; Anticoagulants; Aspirin; Blood Platelets; Brain Ischemia; Coronary Disease; Dipyridamole; D | 1984 |
[Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].
Topics: Anticoagulants; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Flurbiprof | 1980 |
Antithrombotic drugs in relation to prostaglandin metabolism.
Topics: Aspirin; Coronary Disease; Dipyridamole; Extracorporeal Circulation; Fibrinolytic Agents; Heparin; H | 1980 |
Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cell Division; Clinical Trials as Topic; Coronary | 1982 |
Effects of dipyridamole in combination with anticoagulant therapy on survival and thromboembolic events in patients with prosthetic heart valves. A meta-analysis of the randomized trials.
Topics: Anticoagulants; Dipyridamole; Drug Therapy, Combination; Heart Valve Prosthesis; Humans; Randomized | 1995 |
Pharmacokinetic optimisation of the treatment of embolic disorders.
Topics: Anticoagulants; Clinical Trials as Topic; Dipyridamole; Fibrinolytic Agents; Heparin, Low-Molecular- | 1995 |
Oral anticoagulant treatment with and without aspirin.
Topics: Administration, Oral; Angina, Unstable; Anticoagulants; Aspirin; Clinical Trials as Topic; Dipyridam | 1995 |
Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis.
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Heart Valve Prosthesis; Humans; Platelet Aggregati | 2001 |
[Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Analgesics; Anti-Inflammatory Agents; Arterioscl | 1976 |
Platelet function inhibitors: their clinical use.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Disease | 1978 |
[Indications and uncertainties of antiaggregating agents].
Topics: Anticoagulants; Aspirin; Clofibrate; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregati | 1977 |
[Prevention of postoperative thrombo-embolic complications. The principal methods, other than low-dose heparin].
Topics: Anticoagulants; Dextrans; Dipyridamole; Femoral Neck Fractures; Heparin; Hip Joint; Humans; Hydroxyc | 1977 |
[Prophylaxis of thromboembolism using low dosage heparin (author's transl)].
Topics: Antithrombins; Aspirin; Blood Coagulation; Dipyridamole; Drug Therapy, Combination; Heparin; Humans; | 1979 |
Antiplatelet drugs in thromboembolism.
Topics: Anticoagulants; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Drug Therapy, Combination; | 1979 |
Platelet and fibrinogen kinetic evaluation of thrombogenesis.
Topics: Animals; Anti-Inflammatory Agents; Arteriosclerosis; Blood Platelets; Cell Survival; Dipyridamole; F | 1979 |
[Prevention of thrombosis and embolism in digestive surgery].
Topics: Anticoagulants; Aspirin; Coumarins; Dextrans; Digestive System Surgical Procedures; Dipyridamole; He | 1979 |
Platelet inhibitors in the treatment of thrombosis.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Clinical Trials as Topic; Clof | 1978 |
[Treatment with antiplatelet drugs. Current status of knowledge].
Topics: Aspirin; Blood Platelet Disorders; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dextrans | 1979 |
Antiplatelet agents: a review.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofi | 1979 |
[Anticoagulation therapy in myocardial infarction (author's transl)].
Topics: Anticoagulants; Aspirin; Coumarins; Dipyridamole; Fibrinolysis; Heparin; Humans; Leg; Myocardial Inf | 1975 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clo | 1975 |
Clinical trials in thrombosis: secondary prevention of myocardial infarction.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Female; Humans; Male; Myocardial Infarction; Prospe | 1976 |
Antithrombotic drugs: part II.
Topics: Anabolic Agents; Ancrod; Animals; Aspirin; Blood Platelets; Clofibrate; Dextrans; Dipyridamole; Fibr | 1976 |
Are agents affecting platelet functions clinically useful?
Topics: Aged; Animals; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Clofibrate; Dextrans; Dipyrida | 1976 |
Platelets and thromboembolism.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Dext | 1976 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Topics: Animals; Antidepressive Agents, Tricyclic; Aspirin; Blindness; Blood Platelets; Cerebrovascular Diso | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Tria | 1975 |
[Thromboembolus migrating into the right heart in pulmonary embolism. Echocardiographic and clinico-therapeutic aspects in 7 cases and review of the literature].
Topics: Adult; Aged; Aged, 80 and over; Dipyridamole; Echocardiography; Female; Fibrinolytic Agents; Heart D | 1989 |
[Platelet function inhibitors in peripheral arteriopathies].
Topics: Adrenal Cortex Hormones; Adrenergic alpha-Antagonists; Anti-Inflammatory Agents; Arachidonic Acid; A | 1986 |
Preventive cardiology: what is the value of antiplatelet agents and fish oils?
Topics: Aspirin; Cardiovascular Diseases; Coronary Thrombosis; Dipyridamole; Fish Oils; Humans; Platelet Agg | 1988 |
Antithrombotic agents in coronary artery disease.
Topics: Angina, Unstable; Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disea | 1986 |
Clinical aspects of antiplatelet therapy.
Topics: Angina Pectoris; Aspirin; Blood Coagulation Disorders; Clinical Trials as Topic; Dipyridamole; Femal | 1985 |
[Long-term antithrombotic treatment in patients with valve prostheses. Practical management and complications].
Topics: Anticoagulants; Aspirin; Bioprosthesis; Dipyridamole; Heart Valve Prosthesis; Hemorrhage; Humans; Th | 1985 |
[The importance of thrombocytes for thrombogenesis and the pharmacological influencing of thrombocyte function (author's transl)].
Topics: Animals; Anticoagulants; Aspirin; Blood Platelet Disorders; Blood Platelets; Clinical Trials as Topi | 1974 |
Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects.
Topics: Aminocaproates; Anticoagulants; Antifibrinolytic Agents; Blood Coagulation; Blood Platelets; Coumari | 1971 |
Platelets and thrombogenesis--current concepts.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Blood Coagulation; Blood Platelets; Clot Retraction; | 1972 |
Antiplatelet aggregant agents and thrombolytic compounds in myocardial infarction: current status.
Topics: Anticoagulants; Aspirin; Blood Coagulation Factors; Coumarins; Dextrans; Dipyridamole; Fibrinolytic | 1972 |
Prevention and management of venous thrombosis and pulmonary embolism.
Topics: Anticoagulants; Aspirin; Coumarins; Dextrans; Dipyridamole; Female; Heparin; Humans; Male; Methods; | 1973 |
Thromboembolism. Diagnosis and treatment.
Topics: Adult; Aspirin; Dipyridamole; Femoral Vein; Fibrinogen; Heparin; Humans; Iliac Vein; Iodine Radioiso | 1974 |
[Summary: Drugs affecting platelet behaviour; experimental and clinical data (author's transl)].
Topics: Adult; Aspirin; Blood Platelets; Child; Clofibrate; Dextrans; Dipyridamole; Drug Combinations; Graft | 1974 |
Platelet inhibition in the management of thrombosis.
Topics: Aspirin; Blindness; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Dextrans; Dipyridamol | 1974 |
Surgery for aortic valve disease.
Topics: Anemia, Hemolytic; Anemia, Hemolytic, Autoimmune; Animals; Anticoagulants; Aortic Valve Insufficienc | 1971 |
33 trials available for dipyridamole and Thromboembolism
| Article | Year |
|---|---|
Thromboembolism after hip surgery.
Topics: Aspirin; Clinical Trials as Topic; Dextrans; Dihydroergotamine; Dipyridamole; Drug Therapy, Combinat | 1981 |
Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypas | 1982 |
Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Heart Valve Prosthesis; | 1983 |
Registry of prospective clinical trials--fifth report.
Topics: Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Double-Bl | 1982 |
[Prevention of systemic thromboembolic accidents in patients with artificial valve prostheses. Prospective study of an antivitamins K-dipyridamole combination].
Topics: Aortic Valve; Dipyridamole; Drug Therapy, Combination; Heart Valve Prosthesis; Humans; Mitral Valve; | 1982 |
Platelet release reaction in vivo in patients with ischaemic heart disease after isometric exercise and its prevention with dipyridamole.
Topics: Adult; Aged; Blood Platelets; Coronary Disease; Diabetes Mellitus; Dipyridamole; Female; Humans; Iso | 1980 |
Series on pharmacology in practice. 10. Antithrombotic therapy: role of platelet-inhibitor drugs. III. Management of arterial thromboembolic and atherosclerotic disease (third of three parts).
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Coro | 1981 |
[Platelet antiaggregants: review of the literature (author's transl)].
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggrega | 1981 |
Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cell Division; Clinical Trials as Topic; Coronary | 1982 |
Frequency of prosthetic valve-related complications with very low level warfarin anticoagulation combined with dipyridamole after valve replacement using St. Jude Medical prostheses.
Topics: Adult; Dipyridamole; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Valve Pr | 1994 |
[Possibilities and limits of controlled clinical therapy studies for the demonstration of the effectiveness of antithrombotic therapy].
Topics: Adult; Anticoagulants; Aspirin; Clinical Trials as Topic; Dextrans; Dipyridamole; Dose-Response Rela | 1975 |
Platelet inhibitors in the treatment of thrombosis.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Clinical Trials as Topic; Clof | 1978 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clo | 1975 |
Clinical trials in thrombosis: secondary prevention of myocardial infarction.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Female; Humans; Male; Myocardial Infarction; Prospe | 1976 |
Preventing venous thromboembolism in elderly patients with hip fractures: studies of low-dose heparin, dipyridamole, aspirin, and flurbiprofen.
Topics: Age Factors; Aged; Aspirin; Dipyridamole; Drug Evaluation; Femoral Neck Fractures; Flurbiprofen; Hep | 1977 |
The current status of platelet suppressive drugs in the treatment of thrombosis.
Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cardiac Catheterization; Cell Surviva | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Topics: Animals; Antidepressive Agents, Tricyclic; Aspirin; Blindness; Blood Platelets; Cerebrovascular Diso | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Tria | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; Fibrin | 1975 |
Controlled trial of platelet anti-aggregating agents and subcutaneous heparin in prevention of postoperative deep vein thrombosis in high risk patients.
Topics: Aged; Aspirin; Blood Platelets; Dipyridamole; Female; Heparin; Humans; Injections, Subcutaneous; Mal | 1975 |
Comparison of two levels of anticoagulant therapy in patients with substitute heart valves.
Topics: Acenocoumarol; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Va | 1991 |
Dipyridamole combined with anticoagulant in prevention of early postoperative thromboembolism after cardiac valve replacement.
Topics: Adolescent; Adult; Aged; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Heart | 1990 |
[Platelet function inhibitors in peripheral arteriopathies].
Topics: Adrenal Cortex Hormones; Adrenergic alpha-Antagonists; Anti-Inflammatory Agents; Arachidonic Acid; A | 1986 |
Antithrombotic agents in coronary artery disease.
Topics: Angina, Unstable; Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disea | 1986 |
Clinical aspects of antiplatelet therapy.
Topics: Angina Pectoris; Aspirin; Blood Coagulation Disorders; Clinical Trials as Topic; Dipyridamole; Femal | 1985 |
Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial.
Topics: Adult; Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Combinations; Female; Heart Valve Prost | 1985 |
[Dipyridamole and warfarin in patients with artificial heart valve prosthesis: double-blind tests].
Topics: Adolescent; Adult; Aged; Blood Platelets; Cell Survival; Clinical Trials as Topic; Dipyridamole; Dou | 1985 |
[The importance of thrombocytes for thrombogenesis and the pharmacological influencing of thrombocyte function (author's transl)].
Topics: Animals; Anticoagulants; Aspirin; Blood Platelet Disorders; Blood Platelets; Clinical Trials as Topi | 1974 |
Effect of dipyridamole on the incidence of arterial emboli after cardiac valve replacement.
Topics: Adult; Clinical Trials as Topic; Dipyridamole; Embolism; Female; Heart Valve Prosthesis; Humans; Int | 1969 |
Control of thromboembolism from prosthetic heart valves.
Topics: Biomedical Engineering; Clinical Trials as Topic; Dipyridamole; Heart Valve Prosthesis; Humans; Mitr | 1969 |
Pharmacologic control of thromboembolic complications of cardiac-valve replacement.
Topics: Adult; Aged; Aortic Valve; Clinical Trials as Topic; Dipyridamole; Female; Follow-Up Studies; Heart | 1971 |
Reduction in venous thromboembolism by agents affecting platelet function.
Topics: Adult; Aged; Arthroplasty; Aspirin; Blood Platelets; Chromium Alloys; Dextrans; Dipyridamole; Female | 1971 |
Pharmacologic control of thromboembolic complications of cardiac-valve replacement. A preliminary report.
Topics: Adult; Aortic Valve; Atrial Fibrillation; Dipyridamole; Embolism; Female; Follow-Up Studies; Heart V | 1968 |
92 other studies available for dipyridamole and Thromboembolism
| Article | Year |
|---|---|
In vivo toxicity and antithrombotic profile of the oral formulation of the antileukemic agent, LFM-A13-F.
Topics: Administration, Oral; Amides; Animals; Bleeding Time; Blood Cell Count; Blood Coagulation; Collagen; | 2004 |
Antiplatelet therapy.
Topics: Aged; Aspirin; Clopidogrel; Dipyridamole; Drug Interactions; Humans; Myocardial Infarction; Patient | 2004 |
Chronic myocardial infarction due to arteriosclerosis of coronary arteries followed by acute thromboembolism of caudal abdominal aorta in a cat.
Topics: Animals; Aorta, Abdominal; Benzazepines; Cat Diseases; Cats; Coronary Artery Disease; Diltiazem; Dip | 2005 |
Update on the use of antiplatelet agents in secondary stroke prevention.
Topics: Arteriosclerosis; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Embolism, Cholester | 2007 |
[Antithrombotic therapy in ischemic stroke and transient ischemic attack].
Topics: Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; | 2007 |
Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replac | 2007 |
Outcomes associated with combined antiplatelet and anticoagulant therapy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Cohort Studies; Coronary Artery Disea | 2008 |
Dipyrimadole and post-operative hypercoagulability.
Topics: Blood Coagulation; Dipyridamole; Humans; Postoperative Complications; Thromboembolism | 1967 |
[Benefits and dangers of preventive thinking in medicine--prevention of thromboembolism].
Topics: Adult; Aspirin; Bandages; Blood Flow Velocity; Coumarins; Dextrans; Dihydroergotamine; Dipyridamole; | 1981 |
Preliminary experience with aspirin for anticoagulation in children with prosthetic cardiac valves.
Topics: Adolescent; Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Child; Child, Preschool; Dicumarol | 1982 |
Pharmacology of angioplasty and intravascular thrombolysis.
Topics: Angioplasty, Balloon; Anticoagulants; Arteriosclerosis; Aspirin; Blood Platelets; Dextrans; Dipyrida | 1982 |
A method for monitoring ADP-induced thromboembolism in mice.
Topics: Adenosine Diphosphate; Animals; Dipyridamole; Dose-Response Relationship, Drug; Lung; Male; Mice; Mo | 1984 |
Drugs in the treatment of thrombo-embolic disease--part I.
Topics: Administration, Oral; Anticoagulants; Aspirin; Blood Platelets; Carotid Artery Diseases; Cerebrovasc | 1983 |
[Case of mitral stenosis with regression and elimination of left atrial thrombus after combined therapy of urokinase, dipyridamole and aspirin].
Topics: Aged; Aspirin; Dipyridamole; Drug Therapy, Combination; Echocardiography; Female; Heart Atria; Heart | 1983 |
[Is modern anti-aggregation therapy effective?].
Topics: Aspirin; Dipyridamole; Fibrinolytic Agents; Humans; Platelet Aggregation; Sulfinpyrazone; Thromboemb | 1984 |
The prevention of prosthetic valve thromboembolism. Uses and limitations of anti-platelet drugs.
Topics: Anticoagulants; Aspirin; Bioprosthesis; Dipyridamole; Drug Therapy, Combination; Heart Valve Prosthe | 1983 |
[Present situation of therapy with platelet aggregation inhibitors].
Topics: Adult; Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Middle Aged; | 1982 |
[Use of dipyridamole in the prevention of postoperative thromboembolic complications in gynecologic surgery].
Topics: Dipyridamole; Female; Genital Diseases, Female; Humans; Postoperative Complications; Thromboembolism | 1982 |
Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis.
Topics: Adult; Aged; Aortic Valve; Aortic Valve Stenosis; Aspirin; Bioprosthesis; Dipyridamole; Drug Therapy | 1981 |
[Treatment and prevention of thromboembolism with anti-aggregation drugs].
Topics: Aspirin; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone; Thromboembolism | 1981 |
Reduction of platelet activity in patients with prosthetic heart valves.
Topics: Blood Platelets; Dipyridamole; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Platelet A | 1980 |
[Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use].
Topics: Aspirin; Blood Platelet Disorders; Brain Ischemia; Clofibrate; Coronary Disease; Dipyridamole; Human | 1980 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Stud | 1995 |
Antiplatelet therapy in children with left-sided mechanical prostheses.
Topics: Adolescent; Aortic Valve; Aspirin; Child; Child, Preschool; Dipyridamole; Female; Follow-Up Studies; | 1993 |
Antiplatelet therapy in ischaemic events.
Topics: Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Humans; Platelet Aggregation Inhi | 1997 |
Anticoagulation in children with mechanical valve prostheses.
Topics: Adolescent; Anticoagulants; Aspirin; Child; Child, Preschool; Dipyridamole; Female; Heart Valve Pros | 1997 |
[Atrial fibrillation and thromboembolism: a multicenter cooperative study. Research Group for Antiarrhythmic Drug Therapy].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Dipyridamole; Female; Heart Diseases; Humans; Male; Mi | 1998 |
Effect of platelet inhibitors on thromboembolism after implantation of a Novacor N100--preliminary results.
Topics: Anticoagulants; Aspirin; Case-Control Studies; Dipyridamole; Female; Heart-Assist Devices; Heparin; | 1998 |
Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aortic Valve; Aspi | 1999 |
Standard versus low-level anticoagulation combined to low-dose dipyridamole after mitral valve replacement.
Topics: Administration, Oral; Adolescent; Adult; Anticoagulants; Child; Dipyridamole; Drug Therapy, Combinat | 2000 |
[Prevention of thromboembolic disease in patients with heart disease].
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cross-Sectional Studies; Dipyridamole | 2000 |
[Is it worthwhile preventing postoperative thromboembolism?].
Topics: Anticoagulants; Aspirin; Dihydroergotamine; Dipyridamole; Dose-Response Relationship, Drug; Drug The | 1979 |
Management of thrombo-embolism after aortic valve replacement with the Björk-Shiley tilting disc valve. Medicamental prevention with dicumarol in comparison with dipyridamole - acetylsalicylic acid. Surgical treatment of prosthetic thrombosis.
Topics: Adult; Aortic Valve; Aspirin; Cerebral Hemorrhage; Dicumarol; Dipyridamole; Drug Therapy, Combinatio | 1975 |
Dipyridamole in successful management of pregnant woman with prosthetic heart valve.
Topics: Adult; Aortic Valve; Dipyridamole; Female; Heart Valve Prosthesis; Humans; Postoperative Complicatio | 1976 |
Experimental arterial thromboembolism in baboons. Mechanism, quantitation, and pharmacologic prevention.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Blood Transfusion; Dipyridamole; D | 1979 |
[Anti-platelet aggregating drugs in the prevention of thromboembolic diseases].
Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Cardiovascular Diseases; Cerebrovascular Diso | 1975 |
Treating thromboembolic disease.
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Fibrinolytic Agents; Heart Valve Pros | 1977 |
[Therapy with anticoagulants and platelet aggregation inhibitors in extracranial vascular stenoses and occlusions].
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cerebral Infarction; Cerebrovascular Disorders | 1979 |
The effect of acetyl salicylic acid and dipyridamole on thromboembolic complications in splenectomized patients with myelofibrosis.
Topics: Aged; Aspirin; Blood Platelets; Cell Survival; Dipyridamole; Drug Therapy, Combination; Female; Huma | 1979 |
Anticoagulants and the Björk-Shiley prosthesis.
Topics: Anticoagulants; Dipyridamole; Heart Valve Prosthesis; Humans; Postoperative Complications; Thromboem | 1979 |
[Prevention of thromboembolism with antiaggregants (author's transl)].
Topics: Animals; Anticoagulants; Aspirin; Cats; Dipyridamole; Dogs; Drug Synergism; Heparin; Platelet Aggreg | 1977 |
Anticoagulants and the Björk-Shiley prosthesis. Experience of 390 patients.
Topics: Anticoagulants; Dipyridamole; Heart Valve Prosthesis; Humans; Postoperative Complications; Thromboem | 1978 |
Prevention of thromboembolic complications of valve prostheses by agents affecting platelet function.
Topics: Aspirin; Blood Cell Count; Blood Platelets; Child; Child, Preschool; Dipyridamole; Drug Therapy, Com | 1978 |
Drugs with antithrombotic effect: experimental study.
Topics: Animals; Aspirin; Dipyridamole; Drug Synergism; Heparin; Hypoxia; Lysine; Mice; Platelet Aggregation | 1976 |
Drugs affecting platelet behaviour.
Topics: Adenosine Triphosphate; Blood Platelets; Dextrans; Dipyridamole; Heparin; Humans; Platelet Aggregati | 1976 |
Drugs affecting platelet function tests: their effects on haemostasis and surgical bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Coagulation Disorders; Blood Donors; Blood P | 1975 |
Platelet survival time following aortic valve replacement.
Topics: Adult; Aortic Valve; Aortic Valve Insufficiency; Aortic Valve Stenosis; Aspirin; Blood Platelets; Ce | 1975 |
Effects of dipyridamole and acetylsalicylic acid on platelet functions in patients with aortic ball-valve prostheses.
Topics: Aortic Valve; Aspirin; Blood Platelets; Cell Survival; Dipyridamole; Half-Life; Heart Valve Prosthes | 1975 |
Cesarean section in a patient with a mitral valve prosthesis.
Topics: Adult; Cesarean Section; Dipyridamole; Female; Fetal Death; Heart Valve Prosthesis; Hemorrhage; Huma | 1975 |
[Susceptibility of platelet adhesiveness following bone surgery].
Topics: Aspirin; Blood Cell Count; Blood Platelets; Dextrans; Dipyridamole; Humans; Phenylbutazone; Platelet | 1975 |
Prophylaxis of venous thromboembolism.
Topics: Aspirin; Blood Coagulation; Dextrans; Dipyridamole; Ethylestrenol; Fibrinolysis; Heparin; Humans; Ph | 1975 |
Proceedings: Comparative effects of platelet suppressant drugs on platelet survival time.
Topics: Blood Platelets; Cell Survival; Clofibrate; Dipyridamole; Humans; In Vitro Techniques; Sulfinpyrazon | 1975 |
Proceedings: Comparison of in vivo and in vitro effects of platelet function suppressing drugs.
Topics: Animals; Aspirin; Blood Platelets; Cell Survival; Dipyridamole; In Vitro Techniques; Platelet Aggreg | 1975 |
Letter: Intervention of dipyridamole and acetylsalicylic acid in the development of thrombosis in cell-mediated immune reactions: possible mechanism of action.
Topics: Aspirin; Binding Sites, Antibody; Cell Migration Inhibition; Dipyridamole; Humans; Immunity, Cellula | 1975 |
The antithrombotic properties of dipyridamole clinical investigations and results.
Topics: Aspirin; Cell Survival; Dipyridamole; Fibrinolytic Agents; Humans; Platelet Adhesiveness; Platelet A | 1975 |
[Professor van Cauwenberge's conclusion of the day, dedicated to platelet adhesiveness].
Topics: Aspirin; Dipyridamole; Platelet Adhesiveness; Thromboembolism | 1975 |
A new model to evaluate the thrombus formation due to foreign materials in the great vessels, and the effect of dipyridamole and heparin.
Topics: Animals; Catheterization; Dipyridamole; Disease Models, Animal; Foreign Bodies; Heparin; Male; Pulmo | 1976 |
Platelet-inhibitor therapy in cardiovascular disease. Effective defense against thromboembolism.
Topics: Angioplasty, Balloon; Anticoagulants; Aspirin; Bioprosthesis; Blood Platelets; Coronary Disease; Dip | 1985 |
[Thromboembolism and antithrombogenic therapy after prosthetic valve replacement].
Topics: Dipyridamole; Heart Valve Prosthesis; Humans; Platelet Aggregation Inhibitors; Thromboembolism; Ticl | 1988 |
Effective antiplatelet drug concentrations in experimental arterial thromboembolism.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Dipyridamole; Kinetics; Male; Papio; Sulfinpyrazone | 1987 |
[Retrospective study of the use of dipyridamole and acetylsalicylic acid in the pre-, trans- and postoperative periods, in the prevention of thromboembolic complications, in high risk vascular surgery].
Topics: Aspirin; Dipyridamole; Humans; Platelet Aggregation; Postoperative Complications; Retrospective Stud | 1987 |
Platelet aggregation behaviour in patients treated with ticlopidine.
Topics: Adult; Aged; Aspirin; Atrial Fibrillation; Bleeding Time; Dipyridamole; Female; Humans; Male; Middle | 1987 |
Dipyridamole.
Topics: Arterial Occlusive Diseases; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Postoperative Co | 1987 |
Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation.
Topics: Anticoagulants; Aortic Valve; Aspirin; Atrial Fibrillation; Bioprosthesis; Dipyridamole; Drug Therap | 1986 |
Do all patients with mechanical heart valve prostheses need anticoagulant therapy?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Bioprosthesis; Dipyridamole; Drug Therapy, Combination | 1986 |
Aspirin anticoagulation in children with mechanical aortic valves.
Topics: Adolescent; Adult; Anticoagulants; Aortic Valve; Aspirin; Child; Child, Preschool; Dipyridamole; Fem | 1986 |
Platelet antagonists eliminate thromboembolic complications of small-diameter arterial prostheses.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Graft Occlusion, Vascular; Male; Platelet A | 1987 |
Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition.
Topics: Animals; Aspirin; Blood Platelets; Cell Survival; Cyclooxygenase Inhibitors; Dipyridamole; Drug Syne | 1985 |
Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.
Topics: Adolescent; Adult; Aortic Valve; Aspirin; Blood Platelets; Dipyridamole; Female; Follow-Up Studies; | 1986 |
Anticoagulation therapy in children with mechanical prosthetic cardiac valves.
Topics: Aspirin; Child; Child, Preschool; Dipyridamole; Heart Valve Prosthesis; Hemorrhage; Humans; Thromboe | 1985 |
Does dipyridamole have antithrombotic potential?
Topics: Aspirin; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Humans; Myocardial Infarction; P | 1985 |
[Effect of dipyridamole on changes produced by halothane in blood hemostasis].
Topics: Blood Coagulation Tests; Dipyridamole; Female; Halothane; Hemostasis; Humans; Male; Middle Aged; Pla | 1985 |
[Medicamentous prophylaxis of postoperative cardiovascular complications (author's transl)].
Topics: Aged; Cardiovascular Diseases; Digitalis Glycosides; Dipyridamole; Female; Humans; Male; Middle Aged | 1974 |
Platelet survival in patients with homograft and prosthetic heart valves. Correlation with incidence of thromboembolism.
Topics: Anticoagulants; Blood Cell Count; Blood Platelet Disorders; Blood Platelets; Cell Survival; Chromium | 1974 |
[Thromboembolism prevention after heart valve prosthesis in an experimental model].
Topics: Animals; Anticoagulants; Aspirin; Dipyridamole; Disease Models, Animal; Dogs; Heart Valve Prosthesis | 1972 |
[Influencing thrombocyte function with dipyridamol (Curantyl)].
Topics: Blood Platelets; Dipyridamole; Humans; Platelet Adhesiveness; Thromboembolism | 1972 |
Platelet and fibrinogen consumption in man.
Topics: Blood Cell Count; Blood Platelets; Catheterization; Cell Survival; Dipyridamole; Disseminated Intrav | 1972 |
Platelets.
Topics: Aspirin; Blood Platelets; Dipyridamole; Humans; Sulfinpyrazone; Thromboembolism | 1973 |
[Use of anticoagulants in pregnant patients with Starr Edwards cardiac valve prostheses].
Topics: Administration, Oral; Adult; Dipyridamole; Female; Heart Valve Prosthesis; Heparin; Humans; Injectio | 1973 |
[Clinical use of anti-aggregative agents].
Topics: Aspirin; Dipyridamole; Humans; Hydroxychloroquine; Platelet Adhesiveness; Thromboembolism; Thromboph | 1973 |
Inhibition of platelet-induced thrombus formation.
Topics: Adenosine; Adenosine Diphosphate; Aspirin; Blood Platelets; Brain Diseases; Dipyridamole; Epinephrin | 1974 |
[Drug-induced modification of thrombocyte turnover in patients with artificial heart valves].
Topics: Aortic Valve; Aspirin; Blood Platelets; Cell Survival; Chromium Radioisotopes; Dipyridamole; Heart V | 1974 |
Arterial and venous thromboembolism: kinetic characterization and evaluation of therapy.
Topics: Adult; Aged; Arteriosclerosis; Aspirin; Blood Cell Count; Blood Platelets; Dipyridamole; Drug Synerg | 1974 |
Shortened platelet lifespan in patients with hydrocephalus and ventriculojugular shunts: results of preliminary attempts at correction.
Topics: Aspirin; Blood Coagulation Tests; Blood Platelets; Catheterization; Cerebral Ventricles; Cerebrospin | 1972 |
Use of Persantine in preventing thromboembolism following valve replacement.
Topics: Adolescent; Adult; Aortic Valve; Blood Platelets; Dipyridamole; Female; Heart Valve Prosthesis; Huma | 1972 |
Surgery of the mitral valve.
Topics: Anticoagulants; Dipyridamole; Heart Valve Prosthesis; Humans; Methods; Mitral Valve Insufficiency; M | 1971 |
[Positive effect of dipyridamol on a intrinsic coagulation].
Topics: Adult; Animals; Blood Coagulation Disorders; Dipyridamole; Female; Guinea Pigs; Humans; Male; Middle | 1967 |
Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves.
Topics: Aortic Valve; Aspirin; Blood Cell Count; Blood Platelets; Chromium Isotopes; Dipyridamole; Drug Syne | 1970 |
Thromboembolism--a continuing challenge.
Topics: Arteries; Aspirin; Blood Coagulation; Dipyridamole; Drug Synergism; Heart Valve Prosthesis; Humans; | 1970 |
Thrombosis prevention.
Topics: Animals; Arteries; Arthroplasty; Aspirin; Blood Platelets; Dextrans; Dipyridamole; Hemorrhage; Hip; | 1971 |
[Effect of dipyridamole on platelet adhesiveness. Preliminary report].
Topics: Adult; Blood Platelets; Dipyridamole; Female; Humans; Male; Platelet Adhesiveness; Thromboembolism | 1971 |
Platelet thrombosis on prosthetic valves.
Topics: Dipyridamole; Heart Valve Prosthesis; Humans; Postoperative Complications; Thromboembolism | 1968 |